Regenerative Medical Technology Group Inc.: cashflow_financing
| Value | {"amount": -20776, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"} |
|---|---|
| Period | 2022-01-01 – 2022-12-31 |
| Status | current |
| Entity | Regenerative Medical Technology Group Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:54:01.844096+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/d265f00b-a6f5-4d57-acd0-0d1710f9d92c
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001213900-23-029942Retrieved: 2026-08-19T17:54:01.844096+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001760026/cashflow-financing/2022-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/d265f00b-a6f5-4d57-acd0-0d1710f9d92c
History
- no predecessors — first report